NCT05610111View on ClinicalTrials.gov

Adaptive Biobehavioral Control (ABC) in a Closed-Loop System

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

January 18, 2023

Primary Completion Date

September 26, 2024

Study Completion Date

September 28, 2024

Conditions
Type 1 Diabetes
Interventions
DEVICE

CLC + BAM

Closed Loop Control with the Behavioral Adaption Module for 4 weeks

DEVICE

CLC + ABC

Closed Loop Control with Adaptive Biobehavioral Control for 16 weeks

Trial Locations (1)

22903

University of Virginia Center for Diabetes Technology, Charlottesville

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Tandem Diabetes Care, Inc.

INDUSTRY

lead

Sue Brown

OTHER